adverse-reactions

Documents about adverse-reactions

• Routinely Collected Clinical Data and Evaluation of Antimicrobial Target Attainment#833840ClinicalTrials.gov
• Evaluation of nano-curcumin oral formulation efficacy in prevention of chemotherapy-induced adverse reactions in metastatic colorectal cancer patients.#67522NCBI PubMed Central
• Contraindicated drug-drug interactions and associated adverse drug reactions in an observational cohort study of 4543 paediatric hospitalized patients.#418384NCBI PubMed Central
• Retrospective Analysis of Adverse Drug Reactions in Patients with Type 2 Diabetes Mellitus and Development of a Risk Prediction Model.#442875NCBI PubMed Central
• Analysis of Seriousness and Preventability of Adverse Drug Reactions in Patients at a Tertiary Care Teaching Hospital: A Case Series.#461501NCBI PubMed Central
• Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.#803194ClinicalTrials.gov
• Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients Receiving Daclatasvir (DCV) Trio Therapy#867279ClinicalTrials.gov
• Full list of included and excluded records for "Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: a scoping review of the global literature"#228173Ora Oxford University Research
• Secondary data analysis of Adverse Drug Reactions reported by healthcare professionals and patients: interventions to manage ADRs of ACE inhibitors and ARBs.#265423NCBI PubMed Central
• Consensus on the Clinical Use of Pregabalin in Peripheral Neuropathic Pain#307847Europe PMC
• Artificial Intelligence-based predictive models for adverse blood donor reactions: a systematic review of immediate and delayed events and clinical data approaches.#388798NCBI PubMed Central
• KAN-PROSPECT: a Kolmogorov-Arnold Networks-integrated framework for predicting the effects and adverse reactions of natural products via transfer learning.#610335NCBI PubMed Central
• Bupivacaine Levels in Liver Resection Patients#909473ClinicalTrials.gov
• The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole#978792ClinicalTrials.gov
• Survey to Document the Adverse Reactions After Human Papillomavirus Vaccination Among Japanese Female Youth at a University#319326OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Characterization of adverse reactions to two antihistamine drugs: A descriptive analysis from WHO-VigiAccess#450183PLOS
• Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients#846186ClinicalTrials.gov
• Association of Genetic Polymorphisms With Capecitabine-based Chemotherapy Toxicities in Chinese Solid Tumor Patients#878323ClinicalTrials.gov
• Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma#891593ClinicalTrials.gov
• Imaging of Joint Replacement Complications by PET/CT#992886ClinicalTrials.gov
• Analisis Adverse Reactions Penggunaan Transfusi Darah Terhadap Kualitas Hidup Pasien Gagal Ginjal Kronik Di RSUD Dr. Pirngadi Kota Medan Tahun 2022#1023925utndrepository
• Cannabis and Cannabinoid-Related Suspected Adverse Drug Reactions: Global Patterns and Cross-National Analysis Based on VigiBase^® Data#359196Springer Nature OA
• Prediction tools to prioritise hospitalised adult patients at risk of drug related problems: An umbrella review#434543PLOS
• Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors#916735ClinicalTrials.gov
• Medication without harm: policy brief#298160WHO IRIS
• Advanced HIV disease and treatment-related adverse drug reactions among people living with HIV receiving antiretroviral therapy in Tanzania: a multicenter cross-sectional study#329349bioRxiv / medRxiv
• Non-ergot dopamine agonists and the risk of heart failure and other adverse cardiovascular reactions in Parkinson’s disease#368667Repositorio Institucional UCA
• Design and Evaluation of a Gamification-Based Mobile Application for Reporting Adverse Drug Reactions by Patients and Healthcare Professionals: A Pilot Usability Study in Diabetes Care.#425172NCBI PubMed Central
• Assessing safety trends of withdrawn medications: A data-driven pharmacovigilance approach using growth models#5267Europe PMC
• Suplementos alimentares contaminados com esteroides: efeitos adversos e contribuições da biotecnologia na detecção e prevenção#675110DIALNET OAI Articles
• The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer#852958ClinicalTrials.gov
• Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors#859788ClinicalTrials.gov
• HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions#886079ClinicalTrials.gov
• Pharmacogenetic And Molecular Docking Analysis Of Hla-A, -B, And -Drb1 Markers In Antiepileptic Drug-Induced Severe Cutaneous Adverse Reactions In The Iraqi Population#290299USM Repository
• Secondary Restless Legs Syndrome during psychopharmacological treatment: real-world evidence from a multinational pharmacovigilance program#478589Europe PMC
• Adverse reactions following upper arm vs. buttock DTaP vaccination in children: A retrospective observational study in Wuxi, China, 2020-2024.#615991PubMed
• Different Chemotherapy Protocols Combined With Intensity Modulated Radiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma#991906ClinicalTrials.gov
• The third global patient safety challenge: tackling medication-related harm#470964WHO IRIS
• Methodological framework to identify possible adverse drug reactions using population-based administrative data [v1; ref status: indexed, http://f1000r.es/3ys]#20013DOAJ
• Side Effects of Anti-PD-(L)-1 and Anti CTLA-A4 in the Non Small Cells Lung Cancer#148740ClinicalTrials.gov
• Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia#807460ClinicalTrials.gov
• Maximizing Quality of Life After Cancer Through Rehabilitation#860060ClinicalTrials.gov
• A Study on the Efficacy of Immunotherapy, the Occurrence and Severity of Adverse Reactions in Patients with Non-small Cell Lung Cancer in High-altitude Areas#901271ClinicalTrials.gov
• Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging#869523ClinicalTrials.gov
• YouScript IMPACT Registry#811226ClinicalTrials.gov
• Fentanyl OR Esketamine for Traumatic PAIN (FORE-PAIN) Trial#906899ClinicalTrials.gov
• Pharmacogenetic Testing Among Home Health Patients#843260ClinicalTrials.gov
• The quantitative impact of metabolism‐inhibiting drugs on the occurrence of adverse drug reactions — a backward selection approach / Judith Berres, Justyna Wozniak, Hannah Fölsch, Anja Knueppel‐Ruppert, Verena Graeff, Andrea Kriegisch‐Stumpf, Harald Dormann, Julia C. Stingl, Katja S. Just#783938Deutsche Nationalbibliothek
• Jarisch-Herxheimer Reaction as an Uncommon Cause of Abdominal Pain After Syphilis Treatment: Case Report#276118RCAAP
• Influence of drugs on blood potassium levels in older, multi-medicated patients – results of two cohort studies focusing on adverse drug reactions / Thea Laurentius, Esmail Al-Musawer, Katrin Schmitz, Leo Cornelius Bollheimer, Justyna Wozniak, Verena Graeff, Andrea Kriegisch-Stumpf, Anja Knüppel-Ruppert, Harald Dormann, Julia Carolin Stingl, Katja Just#675392Deutsche Nationalbibliothek